Efficacy and safety of recombinant mycobacterium tuberculosis esat-6 protein for diagnosis of pulmonary tuberculosis: A phase ii trial

Medical Science Monitor

Volumn 19, Issue , 2013, Pages 969-977

  Sun, Qing Feng ^a   Xu, Miao ^b   Wu, Jin Guo ^a   Chen, Bao Wen ^b   Du, Wei Xin ^b   Ding, Ji Guang ^a   Shen, Xiao Bing ^b   Su, Cheng ^b   Wen, Jin Sheng ^c   Wang, Guo Zhi ^b  

^a THE THIRD AFFILIATED HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

^c Center for Disease Control and Prevention of Shanggao County   (China)

Author keywords

Phase ii trial; Pulmonary tuberculosis; Recombinant esat 6 protein; Skin testing

Indexed keywords

EARLY SECRETORY ANTIGENIC TARGET 6; TB PPD; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SAFETY; SKIN TEST; SPUTUM SMEAR; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

ADULT; ANALYSIS OF VARIANCE; ANTIGENS, BACTERIAL; AREA UNDER CURVE; BACTERIAL PROTEINS; CHINA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; ROC CURVE; SKIN TESTS; TUBERCULOSIS, PULMONARY;

EID: 84887435980     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.889425     Document Type: Article

References (23)

1. Cegielski JP, Chin DP, Espinal MA et al: The global tuberculosis situation Progress and problems in the 20th century, prospects for the 21st century Infect Dis Clin North Am, 2002; 16: 1-58
2. Corbett EL, Watt CJ, Walker N et al: The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med, 2003; 163: 1009-1021
3. Barry CE III, Boshoff HI, Dartois V et al: The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat Rev Microbiol, 2009; 7: 845-855
4. Guneylioglu D, Yilmaz A, Bilgin S et al: Factors affecting delays in diagnosis and treatment of pulmonary tuberculosis in a tertiary care hospital in Istanbul, Turkey Med Sci Monit, 2004; 10(2): CR62-CR67
5. Xue L, Fletcher GC, Tolkovsky AM: Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution Mol Cell Neurosci, 1999; 14: 180-198
6. Yang XY, Zhang NM, Diao X et al: Epidemiological analysis of pulmonary tuberculosis in Sichuan Province, China, 2000-2006 Int J Infect Dis, 2008; 12: 534-541
7. Pai M, Minion J, Sohn H et al: Novel and improved technologies for tuberculosis diagnosis: progress and challenges Clin Chest Med, 2009; 30: 701-716
8. American Thoracic Society and Centers for Disease Control: Diagnostic standards and classification of tuberculosis Am Rev Respir Dis, 1991; 142: 725-735
9. Harboe M: Antigens of PPD, old tuberculin, and autoclaved Mycobacterium bovis BCG studied by crossed immunoelectrophoresis Am Rev Respir Dis, 1981; 124: 80-87
10. Huebner RE, Schein MF, Bass JB Jr: The tuberculin skin test Clin Infect Dis, 1993; 17: 968-975
11. Mahairas GG, Sabo PJ, Hickey MJ et al: Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M bovis J Bacteriol 1996; 178: 1274-1282
12. Talbot EA, Williams DL, Frothingham R: PCR identification of Mycobacterium bovis BCG J Clin Microbiol, 1997; 35: 566-569
13. Behr MA, Wilson MA, Gill WP et al: Comparative genomics of BCG vaccines by whole-genome DNA microarray Science, 1999; 284: 1520-1523
14. Andersen P, Munk ME, Pollock JM, Doherty TM: Specific immune-based diagnosis of tuberculosis Lancet, 2000; 356: 1099-1104
15. Chen BW, Xu M, Xu JH et al: Gene cloning, expression and potency of recombinant 11 kD protein at RD1 region of Mycobacterium tuberculosis Chin J Biologicals, 2006; 19: 468-470
16. Xu M, Luo YA, Li YL et al: Differentiation of infection with Mycobacterium tuberculosis by recombinant Mycobacterium tuberculosis 11000 protein Chin J Tuberc Respir Dis, 2006; 29: 762-765
17. Du WX, Chen BW, Lu JB et al: Preclinical study and phase I clinical safety evaluation of recombinant Mycobacterium tuberculosis ESAT6 protein Med Sci Monit Basic Res, 2013; 19: 146-152
18. Guidelines for the diagnosis and treatment of pulmonary tuberculosis (2001 Edition) Journal of Internal Intensive Medicine, 2001; 8: 225-229
19. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine Clin Chem, 1993; 39: 561-577
20. Martinez AN, Rhee JT, Small PM, Behr MA: Sex differences in the epidemiology of tuberculosis in San Francisco Int J Tuberc Lung Dis, 2000; 4: 26-31
21. Borgdorff MW, Nagelkerke NJ, Dye C, Nunn P: Gender and tuberculosis: a comparison of prevalence surveys with notification data to explore sex differences in case detection Int J Tuberc Lung Dis, 2000; 4: 123-132
22. Wu X, Zhang L, Zhang J et al: Recombinant early secreted antigen target 6 protein as a skin test antigen for the specific detection of Mycobacterium tuberculosis infection Clin Exp Immunol, 2008; 152: 81-87
23. Arend SM, Franken WP, Aggerbeck H et al: Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection Tuberculosis (Edinb), 2008; 88: 249-261